Ultrasound and Hyaluronate Injection for Fall Risk in Older Women with Knee Osteoarthritis
Effect of Ultrasound With Simultaneous Hyaluronate Injection on Risk of Fall in Geriatric Women With Knee Osteoarthritis
NA · Badr University · NCT06078449
This study is testing if adding ultrasound therapy to hyaluronate injections can help older women with knee osteoarthritis reduce their risk of falling.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 65 Years to 75 Years |
| Sex | Female |
| Sponsor | Badr University (other) |
| Locations | 1 site (Cairo, New Cairo) |
| Trial ID | NCT06078449 on ClinicalTrials.gov |
What this trial studies
This study investigates the combined effects of therapeutic ultrasound and hyaluronate injections on reducing fall risk in geriatric women suffering from knee osteoarthritis. Forty female participants aged 65 to 75 will receive intra-articular hyaluronate injections and will be randomly assigned to either a treatment group receiving ultrasound therapy or a control group receiving only the injections. The aim is to determine if the addition of ultrasound therapy enhances the benefits of hyaluronate injections in improving knee function and reducing fall risk. The study will take place at Badr University and affiliated clinics.
Who should consider this trial
Good fit: Ideal candidates are women aged 65 to 75 with chronic knee osteoarthritis who have not responded to conventional treatments.
Not a fit: Patients younger than 65 or those with mild osteoarthritis may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of falls in older women with knee osteoarthritis, improving their overall mobility and quality of life.
How similar studies have performed: While the combination of ultrasound and hyaluronate injections is a novel approach, previous studies have shown positive outcomes with each treatment individually.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients' ages above 65 years. * Patients diagnosed as chronic osteoarthritis of more than 5 years. * The OA diagnosed as grade (III to V) * Patients failed with conventional treatment. * All patients followed up with the same orthopedic surgeon, and they took the same type of HA intra-articular injection (HA of High MW 3000 kDa). * All patients were medically stable and do not suffer from any other diseases which may affect the trial results. * All patients were not treated with analgesics or any medication which may cause misleading results. * None of the patients received intra-articular hyaluronic acid injection for 1 year or intra-articular corticosteroid injection within the last 3 months. * All patients didn't take or oral glucosamine or chondroitin supplements or stopped these drugs 2-3 months before participating in this study. * Every patient signed a consent form. Exclusion Criteria: * Young individuals (their age is below 65 years old). * Mild degree of OA (grade I \& II). * Patients who had undergone knee arthroscopy, or any knee surgery. * Patients with OA secondary to trauma. * Patients with metal implants. * Patients with CNS dysfunction.
Where this trial is running
Cairo, New Cairo
- Faculty of Physical Therapy, Badr University — Cairo, New Cairo, Egypt (RECRUITING)
Study contacts
- Study coordinator: Hend R Sakr, PhD
- Email: hend.reda@buc.edu.eg
- Phone: +201010151300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Osteo Arthritis Knee, Risk of fall, osteoarthritis, hyaluronate, geriatric females